Other Guidelines | Page 37 | European Cystic Fibrosis Society (ECFS)

Is it possible to monitor young people with cystic fibrosis at home? Results of the CLIMB-CF study

Testicular pain following initiation of elexacaftor/tezacaftor/ivacaftor in males with cystic fibrosis

Lung infection by Pseudomonas aeruginosa in children with cystic fibrosis: risk factors and impact on lung function

How changes in health insurance coverage for young children with CF can impact important health outcomes, such as lung function at 6 years of age

Drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation

Using a digital system, CFHealthHub, to automatically record the use of preventative inhaled treatments as to compare the amount of medicines collected from pharmacy to the amount actually used.

Comparing lung function testing at home vs in the clinic.

A review of sweat testing in Ireland in the era of modern CF care

Sense of Smell in People with Cystic Fibrosis: Impact of Modulator Therapy

A review of three studies examining different aspects of pulmonary exacerbation treatment

first
previous
…
33
34
35
36
37
38
39
40
41
…
next
last